CC-1088

DRUG2 trials

Sponsors

Boston Medical Center, Celgene

Conditions

LeukemiaMyelodysplastic Syndrome

Phase 1

Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia

CompletedNCT00006097

Boston Medical CenterLeukemia

Start: 1999-08-31End: 2005-07-31Updated: 2010-09-22

Phase 2

Study to Determine the Safety and Preliminary Efficacy of CC-1088 in the Treatment of Myelodysplastic Syndromes

CompletedNCT00045786

CelgeneMyelodysplastic Syndrome

Start: 2001-10-31End: 2003-11-30Updated: 2017-04-25